Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
Clinical trial NCT02974803 · TERMINATED
Trial details
- NCT number
- NCT02974803
- Sponsor
- Canadian Cancer Trials Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-09
- Primary completion
- 2020-07-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.